We have developed mathematical models to represent the changes in volume of fluid spaces associated with i.v. administration of a crystalloid solution. Input data for parameter estimations were dilution of blood, measured as reduction of blood haemoglobin concentration. The models were based on the assumption that the body strives to maintain volume homeostasis of fluid spaces and that the rate of restoration is a function of deviation from resting volume. Two models were derived; the first had a single fluid space into which fluid was administered and from which fluid left, the other model had a second fluid space communicating with the first. These models may be useful in the description and analysis of the effects of i. The distribution of water between fluid compartments, such as the intracellular and extracellular spaces, has been studied in classical physiological work.
The distribution of water between fluid compartments, such as the intracellular and extracellular spaces, has been studied in classical physiological work. 1 Tritiated water injected in trace amounts has also been used to describe the disposition of water in an organism. 2 In these studies, the water molecules have been assumed to be distributed within a fluid space of constant volume. Another, and quite different, aspect of water distribution is the changes in volume of fluid spaces when large, as opposed to trace, amounts of water are added to or removed from the body. In this situation, the infused water changes the volume of the fluid compartment it occupies. To our knowledge, this aspect of fluid therapy has not been studied previously. Therefore, we have developed mathematical models of changes in the volumes of the body fluid spaces applicable during and after volume loading.
Methods

THE MODELS
The models described here are referred to as volume-of-fluid-space (VOFS) models ( fig. 1 ). To give the reader an image of the models, they may be thought of as water-filled balloons, because some features can be comprehended more easily by thinking of a fluid space as a volume surrounded by an elastic wall.
The single-fluid space model, VOFS1, is based on the following assumptions: (1) during infusion, fluid enters an expandable fluid space of volume v, at a constant rate, k i ; (2) the expandable fluid space has a target volume V, which the body strives to maintain; (3) volume v changes by fluid being eliminated from the fluid space at a basal rate, k b (perspiration and basal diuresis), and at a controlled rate. The controlled rate is proportional by a constant k r to the relative deviation of v from the target volume V.
From these assumptions, the following differential equation can be derived:
The solution to this equation is given in the appendix.
The two-fluid space model, VOFS2, is based on the following assumptions: (1) during infusion, fluid enters a primary expandable fluid space of volume v 1 at a constant rate, k i ; (2) there is a secondary expandable fluid space of volume, v 2 , exchanging fluid with the primary fluid space; (3) v 1 changes through exchange with the secondary fluid space and as a result of fluid being eliminated from the primary fluid space at a basal rate, k b , and at a controlled rate; (4) the primary and secondary fluid spaces have target volumes V 1 and V 2 which the system strives to maintain by acting upon the controlled elimination mechanism in proportion, k r , to the relative deviation from the target volume of the primary fluid space and by acting upon the fluid exchange mechanism; (5) the net rate of fluid exchange between the fluid spaces is proportional to the difference in relative deviations from the target volumes by a constant k t .
From these assumptions the following system of differential equations can be derived:
The analytical solutions to these differential equations are presented in the appendix.
NUMERICAL METHODS FOR ESTIMATING PARAMETERS
The rate constants k i and k b in equations (1-3) can be considered known; the first because it is under experimental control and the second because it (basal fluid loss) is a well established, but admittedly variable, physiological phenomenon. Also, the ratio (v 1 9V 1 )/V 1 is known because it is the measured dilution of blood. This holds irrespective of whether v 1 corresponds only to blood volume or to blood volume and any fluid space which is in near instantaneous equilibrium with blood. The remaining variables k t , k r , V 1 and V 2 have to be estimated from the experimental data. This can be done by least-squares fitting of the solutions of equations (1-3) (see appendix) to experimental data.
We chose the random search method for the leastsquares fitting procedure to obtain the best estimates of the unknown variables in the general form of the dilution-time curves in VOFS1 and VOFS2. 3 The variation in the parameters to be estimated was initially 0.1 rnd pv, where rnd is a uniform random number between 91.0 and ;1.0 and pv is the presently "best" value of the parameter. The process went on until no improvement of the fit was obtained in 15 trials and then the factor 0.1 was multiplied by 0.3 pv and the process repeated until no improvement was found within 0.001 pv. Calculations were performed on a Macintosh computer using Matlab version 3 (Math Works Inc., Notich, MA, USA). Experience from a large number of experiments analysed showed that convergence was rapid for data with a better fit to VOFS2 while poorly fitting data were accompanied by slow convergence.
EXPERIMENTAL DATA
The curve-fitting procedure was illustrated by data obtained from two volunteer experiments where Ringer's acetate solution 25 ml kg 91 was given by constant rate i.v. infusion over 30 min. The experiments were approved by the Ethics Committee at South Hospital, Stockholm.
Dilution occurring during i.v. infusion of crystalloid solutions can be assumed to indicate an increase in the volume of one or more expandable fluid spaces. Although many markers may be used to indicate dilution, we used blood haemoglobin (B-Hb) concentration, as measured by a Technicon H2 (Bayer, Tarrytown, NY, USA) using colorimetry at 546 nm. Plasma volume was taken to be (19packed cell volume) blood volume. Because our sampling perturbs the volume of the fluid space Figure 2 Plasma dilution-time profiles in two volunteers in whom Ringer's solution 25 ml kg 91 was given by i.v. infusion over 30 min (left). Curve-fitting of the same data was performed according to VOFS1 (middle) and VOFS2 (right), the latter showing the modelled dilution of both the primary (thick line) and secondary (thin line) fluid space. A statistical test applied on the residual errors showed that VOFS1 was most suitable for presentation in first volunteer (top row) while VOFS2 was more appropriate in the second volunteer (bottom row). measured, a correction was introduced based on multiplying the sample volume by the sample B-Hb concentration and then subtracting the amount obtained from total body Hb content, as calculated from estimated blood volume. 4 There are several equations available for estimation of total blood volume from the length and height of human subjects; all give similar results. In this study, the equation of Nadler, Hidalgo and Bloch 5 was used. The dilution-time curves were analysed according to both the VOFS1 and VOFS2 models and a statistical test was applied to the residual errors to select the best for presentation. 3 MODEL SENSITIVITY TO NOISE Identifiableness of parameters was investigated by simulating "exact" data and then estimating them by least squares. Feeding exact data to the program resulted in an output within the precision preset for the algorithm (less than 0.001).
Simulation of statistical error was also performed. For each parameter combination shown in table 2, (v 1 9V 1 )/V 1 was calculated for various times. A random, normally distributed error was then added to each value to investigate the sensitivity of the parameter estimations to noise. The size of the error, and the use of an additive error model, were based on the real situation. B-Hb is a method with an SD of approximately 1 unit of measurement, which is less than 1%. When used to estimate dilution of plasma, the difference between two Hb values is used and the relative size of the error becomes larger than the assay precision. However, the relative size of the error also depends on the magnitude of the dilution. We therefore chose to allow the error to be independent of the parameters and dilution in order to mimic the real situation. Thus, the "standard" SD was chosen as 0.010 dilution units corresponding to approximately 1.4 g litre 91 Hb units. Inspection of the simulation curves shows that they are slightly worse, in terms of error, than real data. The number of times were 12 (0, 2, 6, 12, 20, 22, 26, 32, 40, 50, 90 and 120 min after the start of infusion). For every parameter combination, 25 data sets were simulated, each with random errors, and fitted. Mean, SD, median and, in some cases, geometric mean were calculated.
Results
The VOFS1 model was most suitable for presentation in the first volunteer experiment ( fig. 2, upper  row) . In this case, dilution was similar in the primary The reproducibility of the parameter estimates using different seeds for the random number generator was within 1%.
In the simulation of statistical error, the parameters were varied, as shown in table 2 and illustrated Table 2 Simulated parameter values used to generate the curves in figure 3 (A-K) . For all curves k b :2.5 ml min 91 and the infusion time is 30 min further in figure 3 . The results revealed acceptable precision and lack of bias for V 1 and k r (table 3) . In contrast, V 2 and k t were more sensitive to statistical error and their distributions were also skewed. There was a negative correlation between estimates of V 1 and k t , which illustrates that VOFS is a non-linear model.
Discussion
The clinical basis for this study was the need for methods that allow estimation of the volumes and kinetics of fluid spaces in the body influenced by i.v. infusion of large amounts of fluids. Such methods may be useful for designing and optimizing i.v. fluid therapy. In fact, little is known of how fluid should be administered to yield a certain volume response. Clinical practice is currently the basis for most schemes used. There are several fundamental differences between the VOFS and traditional pharmacokinetic models. The latter describe the distribution of a solute into fluid spaces and binding sites, which themselves are assumed not to be affected by the solute. The volume of distribution is considered to be a constant. Similarly, the target volume of a VOFS model is assumed to be constant, but the size of the fluid space expanded is changed. The size of a target volume can be found only by expanding the fluid space because it is the expandability that distinguishes this fluid space from other parts of the body water.
One important feature of our models is that they take into account differences in compliance with regard to volume expansion between tissues. For example, oedema is usually apparent in the lungs and in the subcutaneous tissue of the legs and around the eyes, while the brain and skeleton are almost unaffected. This illustrates that expandable fluid spaces in a patient are not synonymous with the body fluid compartments usually related to in physiological textbooks. Although the water molecules in a crystalloid solution are distributed throughout the extracellular fluid space, the same fluid might expand a much smaller volume.
A concept of two functionally distinct, but communicating, fluid spaces, one which is rigid and the other expandable, is shown in figure 4 . The difference between the distribution of a trace amount of water injected, the molecules of which may reach any part of the two connected fluid spaces, and the change in volume resulting from an infusion is crucial for the understanding of the VOFS models. A component necessary for estimation of the size of the expandable volume is the existence of the measurable substance confined exclusively to the sampled space. Blood haemoglobin fulfils this criterion.
To avoid confusion, the terminology for the VOFS models was chosen to differ from that used in classical pharmacokinetics. For example, the volume of distribution and clearance of the infused water molecules vary during i.v. infusion. The target volume is a more suitable term as it remains constant. Apart from the differences in terms of interpretation, the mathematical solutions and data analysis have much in common with those used for compartmental models in traditional pharmacokinetics. The VOFS models are based on the assumption that plasma dilution follows a curve with a monoexponential or biexponential component. Non-linear least-squares regression fitting is performed on patient data to obtain estimates of the unknown parameters in these equations. Thereafter, the analytical solutions to the differential equations based on the VOFS model assumptions are used to calculate the sizes of the expandable fluid spaces and the kinetic constants determining the distribution of fluid.
The results of the simulations of different parameter values demonstrate that dilution of blood varies considerably depending on the sizes of the fluid spaces and the rapidity of the transport between them. It is of interest that our calculations gave the dilution-time profile of a secondary fluid space, which probably corresponds to the extracellular fluid of some peripheral tissues. This has previously been difficult to study. The fact that a secondary fluid space may be detected has implications for the design of optimal i.v. fluid therapy and, possibly, to the choice of strategy in oedema treatment.
The statistical simulations showed some important properties of our model. The non-linearity of the parameters was reflected in a correlation between parameter estimates. This non-linearity also expressed itself in the distributions of V 2 and k t , which tended to be positively skewed in some circumstances which can, to some extent, be controlled for in clinical and experimental work. In particular, the dilution measurement needs to be precise because, if the dilution is small owing to a small k i , the error may be very large in comparison with the dilution and result in overestimation of V 2 and k t . One method of improving the estimate of the parameters is to use the geometric mean, unless the experimental conditions can be improved by increasing the dose of the fluid given, shortening the infusion time or using a more precise haemoglobin assay. Approximately 100 i.v. infusions have been carried out for which volume kinetics have been calculated. Our experience with these models is that they "behave well" when real data are applied. Biological findings obtained using the VOFS models, and recommendations for infusion rates, are discussed in subsequent studies. 
Rewriting to conform with the experimental data, X, Y, Q 1 , Q 2 and Q 3 can be estimated from the dilution data from the following expression, which is valid during infusion: 
